Dublin, 27 April 2024: Months after the FDA warned clinicians about plastic syringes made in China, the agency listed violations it discovered at Cardinal Health related to the marketing of unapproved and adulterated syringes. 

 

In an April 24  View Details

Related News

• Cipla gets nod to market Afrezza insulin inhalation powder in India (12-12-2024)

---

• UK regulator probes anti-depressants safety alerts after suicide link (12-12-2024)

---

• Haryana Food Department to Crack Down on Fake Protein Supplements After Major Bust (12-12-2024)

---

• Drug inspector sentenced to 3-yr rigorous imprisonment (12-12-2024)

---

• 11.12 crore worth of short-shelf life medicines expired due to delayed supply to TNMSC: CAG Report (12-12-2024)

---

• Ayush Ministry amends D&C Act to add Homoeopathy, Sowa Rigpa books and Pharmacopoeias (12-12-2024)

---

• Construction of all three bulk drug parks are in progress: Ministry of chemicals (12-12-2024)

---

• Four-member gang nabbed for selling ‘Mephentermine Sulphate’ injections in Hyderabad (12-12-2024)

---

• Combining BCL-2 and BTK inhibitors shows promise in chronic lymphocytic leukemia (CLL) (11-12-2024)

---

• Punjab cop arrests man for narcotic drugs case, gets fined by court (11-12-2024)

---